Report Description

Global Lateral Flow Assay Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of infectious diseases such as TB, Hepatitis, and Influenza, STI along with the growing demand for point-of-care testing. Similarly, the growing adoption of new technology like lateral flow assay kits is expected to create significant growth during the forecast period. Additionally, growing geriatric populations are susceptible to different types of chronic diseases which is enhance the demand for home-based testing methods, this, in turn, is expected to boost the market growth during the forecast period. Besides, growing public awareness about the new testing assay is also propelling market growth through 2028. This, during the 2019-2020 flu season, there were 36 million cases of influenza in the United States.The number of influenza deaths during the 2019-2020 flu season was 20,342. The vast majority of deaths attributed to influenza during the 2019-2020 flu season occurred among those aged 65 years and older. Lateral flow assay is a simple, rapid, and cost-effective diagnostic testing method that has a wide range of applications in various fields. It provides rapid and accurate results, making it ideal for point-of-care testing and other applications where quick results are essential. As technology continues to improve, lateral flow assay is expected to play an increasingly important role in diagnostic testing, food safety testing, and environmental monitoring, among other areas. While lateral flow assays are quick and easy to use, they have some limitations in terms of sensitivity and specificity. This can result in false negatives or false positives, which can impact the accuracy of diagnostic results. The global lateral flow assay market is highly competitive, with many established players and new entrants competing for market share.

This can make it difficult for smaller companies to enter and succeed in the market. Developing and manufacturing lateral flow assays requires specialized expertise in areas such as biochemistry, engineering, and materials science. This can be a barrier to entry for new companies or individuals looking to enter the market. The development and commercialization of lateral flow assays are subject to regulatory requirements in different countries and regions. This can create additional costs and delays for companies looking to bring their products to market. The supply chain for lateral flow assays can be complex, with multiple components and materials sourced from different suppliers. This can increase the risk of supply chain disruptions and impact the availability and quality of products. While lateral flow assays are generally less expensive than other diagnostic tests, cost pressures can still be a challenge for manufacturers. This can impact their ability to invest in research and development, and to offer competitive pricing for their products. Lateral flow assay is widely used for the rapid and accurate detection of infectious diseases, such as HIV, tuberculosis, and malaria, among others. Lateral flow assay is used for the detection of foodborne pathogens, such as Salmonella and E. coli, in food samples.

Growing prevalence of infectious diseases

Chronic illnesses such as cystic fibrosis, cardiovascular diseases, hepatitis, and cancer are rapidly increasing due to physiological changes, metabolic problems, and low immune systems, and so the aging population is prone to these types of chronic diseases which will enhance the growth of the market during the forecast period. Similarly, changing a healthy lifestyle will enhance disease growth across the region and this in turn will boost the market growth during the forecast period. In September 2020, Qiagen N.V. bought NeuMoDx Molecular, Inc. to expand Qiagen's diagnostics instrument product line and boost its market position in automated molecular testing. This will broaden QIAGEN's offering of automated testing solutions and serve as another catalyst for future growth. Government initiative and awareness about using new assays will boost the market growth during the forecast period. During 2021, a total of 7,860 TB cases were provisionally reported to CDC’s National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC). The increasing prevalence of infectious diseases like HIV and malaria due to consuming unhealthy food is expected to create lucrative growth during the forecast period. Due to the increasing prevalence of chronic diseases demand leading a healthy lifestyle increased which is further expected to drive the growth of the market over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions. Infectious diseases are a major global health concern, and the need for rapid and accurate diagnostic tests is essential for effective disease management. LFAs are widely used for the detection of infectious diseases such as HIV, tuberculosis, and malaria, among others. Point-of-care testing refers to diagnostic testing that is performed at or near the site of patient care. LFAs are ideal for point-of-care testing because they are simple to use, require minimal sample preparation, and can provide results within minutes. With the COVID-19 pandemic, there has been a growing demand for home-based and self-testing. LFAs are well suited for home-based and self-testing due to their ease of use and quick results. The growing demand for personalized medicine is driving the development of lateral flow assays that can be used for patient-specific diagnosis and treatment.

Increasing demand for home-based testing method

Rising demand for home-based testing kits for the detection of chronic diseases, pregnancy tests, fertility tests, coagulation tests urine chemistry, etc, the growing demand for point-of-care testing may further enhance the demand for lateral flow assay and usage of this device is rapidly increased which may further propel the growth of the market during the forecast period. According to this Statista, 7.92 million women in the U.S. used home pregnancy tests in 2020. Major companies are focusing on developing innovative lateral flow assay-based point-of-care devices for applications such as pregnancy tests by using HCG levels and ovulation, careening for infectious diseases ad drugs, and the measurement of protein markers in the boost is expected to enhance the demand for lateral flow assay market over the years. For instance, in 2019, Abbott Laboratories (US) developed its ARCHITECT stat Troponin I blood test, while Siemens AG developed the CLINITEK Microalbumin 2 strips for clinical diagnostics. Investment in research and development is driving innovation in lateral flow assays, leading to the development of new and improved assays for diagnostic testing. Technological advancements in lateral flow assays are improving their sensitivity, specificity, and accuracy, making them more effective and reliable for diagnostic testing.

Recent Development

  • Novacyt, a specialist in clinical diagnostics, is to launch two PathFlow COVID-19 antigen lateral flow tests (LFTs) to strengthen its COVID-19 portfolio and to pursue new market opportunities, especially in point-of-care (POC) settings. In September 2020, F. Hoffmann-La Roche AG (Switzerland) launched a SARS-CoV-2 rapid antigen test kit and a SARS-CoV-2 rapid antibody test kit.
  • Many lateral flow assays for the detection of SARS-CoV-2 (the virus that causes COVID-19) have been launched in the past three years. For example, in 2020, Roche launched a rapid antigen test for COVID-19 that uses a lateral flow assay, and in 2021, Abbott Laboratories launched a lateral flow assay for the detection of COVID-19 antigens.
  • Several lateral flow assays for the detection of influenza have been launched in the past three years. For example, in 2019, Quidel Corporation launched a lateral flow assay for the detection of influenza A and B viruses, and in 2021, Luminex Corporation launched a lateral flow assay for the detection of influenza A and B viruses and respiratory syncytial virus.
  • Multiplex lateral flow assays that can detect multiple targets in a single test have also been launched in the past three years. For example, in 2020, Abingdon Health launched a multiplex lateral flow assay for the detection of multiple sexually transmitted infections, and in 2021, Mologic launched a lateral flow assay for the detection of three different biomarkers for preeclampsia.
  • Digital lateral flow assays that use smartphone technology for result interpretation have also been launched in the past three years. For example, in 2019, Biosense Technologies launched a digital lateral flow assay for the detection of dengue fever, and in 2021, OraSure Technologies launched a digital lateral flow assay for the detection of HIV.


Download Free Sample Report

Market Segmentation

Global lateral flow assay market can be segmented by product, application, technique, test type, end-user, and by region. Based on the product, the market can be segmented into Kits & Reagents, Lateral Flow Readers, and Others. Based on application, the market can be segmented into Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, and Others. Based on technique, the market can be differentiated by Sandwich Assay, Competitive Assay, and Multiplex Detection Assay. Based on test type, the market can be divided into Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay. Based on end-user, the market can be differentiated into Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among different countries, the United States dominates the global lateral flow assay market on account of the growing prevalence of infectious diseases and the demand for new technology with affordable costs in the country. Reported TB incidence (cases per 100,000 persons) increased 9.4%, from 2.2 during 2020 to 2.4 during 2021 but was lower than incidence during 2019 (2.7). Increases occurred among both U.S.-born and non–U.S.-born persons.

Market Players

Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMérieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V. are some of the leading players operating in the Global Lateral Flow Assay Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         By Product

·         By Application

·         By Technique

·         By Test Type

·         By End User

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; South Korea; Japan; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMérieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, the global lateral flow assay market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Lateral Flow AssayMarket, By Product:

o    Kits & Reagents

o    Lateral Flow Readers

o    Others

  • Lateral Flow AssayMarket, By Application:

o    Clinical Testing

o    Cardiac Marker Testing

o    Pregnancy & Fertility Testing

o    Veterinary Diagnostics

o    Others

  • Lateral Flow AssayMarket, By Technique:

o    Sandwich Assay

o    Competitive Assay

o    Multiplex Detection Assay

  • Lateral Flow Assay Market, By Test Type:

o    Lateral Flow Immunoassay

o    Nucleic Acid Lateral Flow Assay

  • Lateral Flow Assay Market, By End User:

o    Hospitals & Clinics

o    Diagnostic Laboratories

o    Others

  • Lateral Flow Assay Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • South Korea
      • Japan
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lateral Flow Assay Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Lateral Flow Assay Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Lateral Flow Assay Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Kits & Reagents, Lateral Flow Readers, Others)

5.2.2.     By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)

5.2.2.1.         By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)

5.2.2.2.         By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)

5.2.2.3.         By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)

5.2.3.     By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)

5.2.4.     By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)

5.2.5.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)

5.2.6.     By Region

5.2.7.     By Company (2022)

5.3.  Market Map

5.3.1.     By Product

5.3.2.     By Application

5.3.3.     By Technique

5.3.4.     By Test Type

5.3.5.     By End User

5.3.6.     By Region

6.    North America Lateral Flow Assay Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Kits & Reagents, Lateral Flow Readers, Others)

6.2.2.     By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)

6.2.2.1.         By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)

6.2.2.2.         By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)

6.2.2.3.         By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)

6.2.3.     By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)

6.2.4.     By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)

6.2.5.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)

6.2.6.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Lateral Flow Assay Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product

6.3.1.2.2.             By Application

6.3.1.2.3.             By Technique

6.3.1.2.4.             By Test Type

6.3.1.2.5.             By End User 

6.3.2.     Mexico Lateral Flow Assay Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product

6.3.2.2.2.             By Application

6.3.2.2.3.             By Technique

6.3.2.2.4.             By Test Type

6.3.2.2.5.             By End User 

6.3.3.     Canada Lateral Flow Assay Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product

6.3.3.2.2.             By Application

6.3.3.2.3.             By Technique

6.3.3.2.4.             By Test Type

6.3.3.2.5.             By End User 

7.    Europe Lateral Flow Assay Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Kits & Reagents, Lateral Flow Readers, Others)

7.2.2.     By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)

7.2.2.1.         By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)

7.2.2.2.         By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)

7.2.2.3.         By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)

7.2.3.     By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)

7.2.4.     By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)

7.2.5.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)

7.2.6.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Lateral Flow Assay Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Application

7.3.1.2.3.             By Technique

7.3.1.2.4.             By Test Type

7.3.1.2.5.             By End User 

7.3.2.     Germany Lateral Flow Assay Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Application

7.3.2.2.3.             By Technique

7.3.2.2.4.             By Test Type

7.3.2.2.5.             By End User 

7.3.3.     United Kingdom Lateral Flow Assay Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Application

7.3.3.2.3.             By Technique

7.3.3.2.4.             By Test Type

7.3.3.2.5.             By End User 

7.3.4.     Italy Lateral Flow Assay Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Application

7.3.4.2.3.             By Technique

7.3.4.2.4.             By Test Type

7.3.4.2.5.             By End User 

7.3.5.     Spain Lateral Flow Assay Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Application

7.3.5.2.3.             By Technique

7.3.5.2.4.             By Test Type

7.3.5.2.5.             By End User 

8.    Asia-Pacific Lateral Flow Assay Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product (Kits & Reagents, Lateral Flow Readers, Others)

8.2.2.     By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)

8.2.2.1.         By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)

8.2.2.2.         By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)

8.2.2.3.         By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)

8.2.3.     By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)

8.2.4.     By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)

8.2.5.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)

8.2.6.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Lateral Flow Assay Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Application

8.3.1.2.3.             By Technique

8.3.1.2.4.             By Test Type

8.3.1.2.5.             By End User 

8.3.2.     India Lateral Flow Assay Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Application

8.3.2.2.3.             By Technique

8.3.2.2.4.             By Test Type

8.3.2.2.5.             By End User 

8.3.3.     South Korea Lateral Flow Assay Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Application

8.3.3.2.3.             By Technique

8.3.3.2.4.             By Test Type

8.3.3.2.5.             By End User 

8.3.4.     Japan Lateral Flow Assay Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Application

8.3.4.2.3.             By Technique

8.3.4.2.4.             By Test Type

8.3.4.2.5.             By End User 

8.3.5.     Australia Lateral Flow Assay Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Application

8.3.5.2.3.             By Technique

8.3.5.2.4.             By Test Type

8.3.5.2.5.             By End User 

9.    South America Lateral Flow Assay Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product (Kits & Reagents, Lateral Flow Readers, Others)

9.2.2.     By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)

9.2.2.1.         By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)

9.2.2.2.         By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)

9.2.2.3.         By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)

9.2.3.     By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)

9.2.4.     By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)

9.2.5.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)

9.2.6.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Lateral Flow Assay Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Application

9.3.1.2.3.             By Technique

9.3.1.2.4.             By Test Type

9.3.1.2.5.             By End User 

9.3.2.     Argentina Lateral Flow Assay Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Application

9.3.2.2.3.             By Technique

9.3.2.2.4.             By Test Type

9.3.2.2.5.             By End User 

9.3.3.     Colombia Lateral Flow Assay Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Application

9.3.3.2.3.             By Technique

9.3.3.2.4.             By Test Type

9.3.3.2.5.             By End User 

10.  Middle East and Africa Lateral Flow Assay Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product (Kits & Reagents, Lateral Flow Readers, Others)

10.2.2.  By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)

10.2.2.1.      By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)

10.2.2.2.      By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)

10.2.2.3.      By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)

10.2.3.  By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)

10.2.4.  By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)

10.2.5.  By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)

10.2.6.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Lateral Flow Assay Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Application

10.3.1.2.3.           By Technique

10.3.1.2.4.           By Test Type

10.3.1.2.5.           By End User 

10.3.2.  Saudi Arabia Lateral Flow Assay Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Application

10.3.2.2.3.           By Technique

10.3.2.2.4.           By Test Type

10.3.2.2.5.           By End User 

10.3.3.  UAE Lateral Flow Assay Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Application

10.3.3.2.3.           By Technique

10.3.3.2.4.           By Test Type

10.3.3.2.5.           By End User 

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Developments

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Lateral Flow Assay Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Product Offerings

15.3.              Recent Developments

15.4.              Financials (As Reported)

15.5.              Key Personnel

15.6.              SWOT Analysis

 

15.6.1    Thermo Fisher Scientific, Inc.

15.6.2    Abbott Laboratories, Inc.

15.6.3    F. Hoffmann-La Roche AG

15.6.4    Bio-Rad Laboratories, Inc.

15.6.5    Quidel Corporation

15.6.6    Hologic, Inc.

15.6.7    bioMérieux SA

15.6.8    PerkinElmer, Inc.

15.6.9    Danaher Corporation

15.6.10 QIAGEN N.V.

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The growing prevalence of infectious diseases such as TB, STDs, and Influenza along with the demand for point care testing such as COVID-19 antigen lateral flow assay test are some of the major factors driving the growth of the global lateral flow assay market.

down-arrow

Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMérieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V. are some of the leading players operating in the Global Lateral Flow Assay Market.

down-arrow

The kits and reagents segment expectedly dominates the global lateral flow assay market during the forecast period.

down-arrow

North American region is expected to hold the largest share in the Lateral Flow Assay Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Lateral Flow Assay Market to be dominated by Kits and Reagents type through 2028

Dec, 2022

The increase in the prevalence of infectious diseases is expected to drive the growth of global lateral flow assay in the forecast period, 2024-2028.